This inventor holds 16 USPTO granted patents and 9 published patent applications. Top assignees: General Electric Company, Owp Pharmaceuticals, Inc., Other. Active years: 1993-2026.
Location History:
- North Providence, RI (US) (1993)
- West Chicago, IL (US) (2021 - 2024)
Company Filing History:
2 out of 52,359 
2 out of 2 
5 out of 834,411 Years Active: 1993-2026
Title: The Innovations of Scott Boyer
Introduction
Scott Boyer is a notable inventor based in West Chicago, Illinois. He has made significant contributions to the field of pharmaceuticals, holding a total of 10 patents. His work primarily focuses on developing oral liquid suspensions for various medications.
Latest Patents
Among his latest patents are the "Topiramate oral liquid suspension and use thereof" and the "Quetiapine oral liquid suspension and use thereof." The first patent provides an oral liquid suspension that includes topiramate, along with methods for medical treatment that involve orally administering this suspension. The second patent offers an oral liquid suspension containing quetiapine or a pharmaceutically acceptable salt thereof, detailing a method for orally delivering quetiapine fumarate to treat mental disorders such as schizophrenia, bipolar mania, and bipolar depression.
Career Highlights
Scott Boyer has worked with prominent companies, including General Electric Company. His experience in the industry has allowed him to develop innovative solutions that address critical medical needs.
Collaborations
Throughout his career, Scott has collaborated with notable individuals such as Paul Sudhakar and Ralph L. Graves. These partnerships have contributed to the advancement of his inventions and the successful development of his patents.
Conclusion
Scott Boyer exemplifies the spirit of innovation in the pharmaceutical industry. His contributions through his patents have the potential to improve the quality of life for many individuals.